Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Keratinocyte proliferation targets" refers to the network of genes, proteins, and signaling molecules that regulate the multiplication and cell cycle progression of keratinocytes in the epidermis. Key regulators include transcription factors (such as p63, c-MYC), signaling pathways (Wnt/β-catenin, PI3K/Akt, Notch), and specific keratin proteins (K5, K14, K17). These molecules collectively balance keratinocyte growth and differentiation, essential for epidermal homeostasis, wound healing, and barrier function. Dysregulation of these targets is linked to increased risk of skin cancers (e.g., squamous cell carcinoma, basal cell carcinoma), skin disorders (e.g., psoriasis, delayed wound healing), and abnormal responses to microbial colonization. However, "keratinocyte proliferation targets" does not denote a single molecular entity and is not a valid canonical target name[1][2][3][4][5][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratinocyte proliferation targets.